On August 5, 2026, iRhythm Holdings, Inc. entered into an Agreement and Plan of Merger to acquire Vital Connect, Inc. The transaction involves aggregate consideration consisting of $237.5 million in cash and shares of iRhythm common stock valued at $50 million. Outstanding Target options will be cancelled without consideration, while vested and in-the-money warrants are eligible for equity consideration. An interim funding agreement provides up to $30.0 million in pre-closing operational support, with an initial $10.0 million grant. The acquisition is expected to close by the end of 2026, subject to stockholder approval and Hart-Scott-Rodino antitrust clearance. iRhythm operates in the digital health industry, developing wearable cardiac monitoring devices.
